TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

King Pharmaceuticals, Inc. Board Under Investors Investigation

  • If you are a current investor in King Pharmaceuticals, Inc. (NYSE:KG) shares, and/or have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

In response to the buyout offer by Pfizer to take over King Pharmaceuticals, Inc. at $14.25 an investigation on behalf of investors of King Pharmaceuticals, Inc. (NYSE:KG) over possible breaches of fiduciary duties in connection with the proposed takeover was announced. The investigation by a law firm concern whether King Pharmaceuticals and its Board of Directors breached their fidu...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: